ENPATH MEDICAL INC
Net SellingNPTH·US·🇺🇸 US
0%buys·100%sales
112 transactions$0Total buys·0 buys
$4.0MTotal sells·18 sells
1616 insiders
Last: Jun 19, 2007
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Jun 19, 07 | YOUNGSTROM SCOTT P | Disposition | $60K | |
| Jun 15, 07 | HEADLEY ANTHONY | Disposition | $77K | |
| Jun 15, 07 | AUTH THOMAS L | Disposition | $134K | |
| Jun 15, 07 | AUTH THOMAS L | Disposition | $14K | |
| Jun 15, 07 | AUTH THOMAS L | Disposition | $23K | |
| Jun 15, 07 | ERDMANN MICHAEL | Disposition | $23K | |
| Jun 15, 07 | ERDMANN MICHAEL | Disposition | $21K | |
| Jun 15, 07 | ERDMANN MICHAEL | Disposition | $15K | |
| Jun 15, 07 | ERDMANN MICHAEL | Disposition | $4K | |
| Jun 15, 07 | ERDMANN MICHAEL | Disposition | $28K |
ENPATH MEDICAL INC (NPTH) has recorded 112 insider transactions from 16 insiders. Total insider buying volume stands at $0, while total selling volume is $4.0M. Overall insider sentiment is bearish (100% sales).
ENPATH MEDICAL INC (NPTH) has recorded 112 insider operations, including 0 open-market purchases ($0), 18 sales ($4.0M) and 94 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (100% sales).
Recent activity is concentrated over 3 months in the last year.
Among the most active insiders are HARTMAN JAMES D (CEO), Hertig John C (CEO) & YOUNGSTROM SCOTT P (CFO), with respectively 66, 9, 10 transactions.
Across all 112 recorded transactions, the breakdown by type is: disposition (48, 43%), grant (28, 25%), exercise (18, 16%), sales (18, 16%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
ENPATH MEDICAL INC has recorded 112 insider operations in total, including 0 open-market purchases ($0), 18 sales ($4.0M) and 94 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on June 19, 2007.
Insiders at ENPATH MEDICAL INC are currently net sellers, with 0% purchases and 100% sales across all reported transactions. Total buy volume is $0 versus $4.0M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 16 insiders at ENPATH MEDICAL INC (NPTH). HARTMAN JAMES D (CEO, 66 tx), Hertig John C (CEO, 9 tx), YOUNGSTROM SCOTT P (CFO, 10 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for NPTH is bearish, based on a 0% buy ratio across 18 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for ENPATH MEDICAL INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.